Cholesterol Drug: Sanofi and Regeneron Say New Medication Can Cut Srokes and Heart Attacks by 50 Percent

September 1, 2014 2:45 PM

11 0

Sanofi and Regeneron Pharmaceuticals have developed an experimental drug that can reduce the number of heart attacks and strokes of patients by 50 percent by decreasing the amount of bad cholesterol in the body.

Sanofi and Regeneron Pharmaceuticals have developed an experimental drug that can reduce the number of heart attacks and strokes of patients by 50 percent by decreasing the amount of bad cholesterol in the body.

Read more

To category page

Loading...